This example shows a selection of programming code document references specified in the documentRef attribute of the codeTemplate for 1 analysis method, and the programmingCode for 1 analysis and 2 outputs:
| Lines 2-7: | Show the code template specified for the "Analysis of variance group comparison for a continuous variable" analysis method, which indicates that relevant R version 4.2.3 program statements can be found in the reference document identified as "anova_R". As there is no page reference, this indicates that the whole reference document contains relevant program statements. |
| Lines 11-25: | Show the programming code specification for the "Comparison of Age Group by Treatment" analysis, which indicates that relevant SAS version 9.4 program statements can be found in the reference document identified as "PROGRAM_CATALOG_SAS" which, in this example, is a single file containing a combined set of programs, with a bookmark created for each program. The sponsor chose to create two separate page references in order to provide a descriptive label for each. |
| Lines 29-34: | Show the programming code specification for the "Summary of TEAE by System Organ Class and Preferred Term" output, which indicates that relevant SAS version 9.4 program statements can be found in the reference document identified as "at14-5-01_sas". As there is no page reference, this indicates that the whole reference document contains relevant program statements. |
YAML Example
methods:
- id: Mth01_CatVar_Summ_ByGrp
name: Summary by group of a categorical variable
operations:
- id: Mth01_CatVar_Summ_ByGrp_1_n
name: Count of subjects
label: n
resultPattern: XXX
- id: Mth01_CatVar_Summ_ByGrp_2_pct
name: Percent of subjects
label: '%'
resultPattern: ( XX.X)
...
...
analyses:
- id: An03_03_Sex_Summ_ByTrt
name: Summary of Subjects by Treatment and Sex
version: 1
methodId: Mth01_CatVar_Summ_ByGrp
analysisSetId: AnalysisSet_02_SAF
orderedGroupings:
- order: 1
resultsByGroup: true
groupingId: AnlsGrouping_01_Trt
- order: 2
resultsByGroup: true
groupingId: AnlsGrouping_02_Sex
results:
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_1
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '33'
formattedValue: '33'
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_1
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '53'
formattedValue: '53'
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_2
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '34'
formattedValue: '34'
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_2
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '50'
formattedValue: '50'
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_3
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '44'
formattedValue: '44'
- operationId: Mth01_CatVar_Summ_ByGrp_1_n
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_3
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '40'
formattedValue: '40'
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_1
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '38.372093023255815'
formattedValue: ( 38.4)
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_1
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '61.627906976744185'
formattedValue: ( 61.6)
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_2
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '40.476190476190474'
formattedValue: ( 40.5)
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_2
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '59.523809523809526'
formattedValue: ( 59.5)
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_3
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_1
rawValue: '52.38095238095238'
formattedValue: ( 52.4)
- operationId: Mth01_CatVar_Summ_ByGrp_2_pct
resultGroups:
- groupingId: AnlsGrouping_01_Trt
groupId: AnlsGrouping_01_Trt_3
- groupingId: AnlsGrouping_02_Sex
groupId: AnlsGrouping_02_Sex_2
rawValue: '47.61904761904762'
formattedValue: ( 47.6)
...
...
The results for this analysis could be represented in tabular format as shown in the following table where the groupingId and groupId from the 2 two instances of the ResultGroup class found in the resultGroups attribute for each each result are represented in separate pairs of columns ("resultGroup1_groupingId"/"resultGroup1_groupId" and "resultGroup2_groupingId"/"resultGroup2_groupId"):
$titleHtml
$warningHtml
Alternatively, to aid readability, each of the identifier values could be used to retrieve and include additional descriptive information from the definitions of the analysis, operations, grouping factors, and groups:| analysis_id | operationId | resultGroup1_groupingId | resultGroup1_groupId | resultGroup2_groupingId | resultGroup2_groupId | rawValue | formattedValue |
|---|---|---|---|---|---|---|---|
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 33 | 33 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 53 | 53 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 34 | 34 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 50 | 50 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 44 | 44 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 40 | 40 |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 38.3720930232558 | ( 38.4) |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 61.6279069767442 | ( 61.6) |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 40.4761904761905 | ( 40.5) |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 59.5238095238095 | ( 59.5) |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 52.3809523809524 | ( 52.4) |
| An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 47.6190476190476 | ( 47.6) |
$titleHtml
$warningHtml
| analysis_id | analysis_name | operationId | operation_label | resultGroup1_groupingId | resultGroup1_grouping_label | resultGroup1_groupId | resultGroup1_group_label | resultGroup2_groupingId | resultGroup2_grouping_label | resultGroup2_groupId | resultGroup2_group_label | rawValue | formattedValue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 33 | 33 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 53 | 53 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 34 | 34 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 50 | 50 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 44 | 44 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 40 | 40 |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 38.3720930232558 | ( 38.4) |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 61.6279069767442 | ( 61.6) |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 40.4761904761905 | ( 40.5) |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 59.5238095238095 | ( 59.5) |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_1 | Male | 52.3809523809524 | ( 52.4) |
| An03_03_Sex_Summ_ByTrt | Summary of Subjects by Treatment and Sex | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Gender | AnlsGrouping_02_Sex_2 | Female | 47.6190476190476 | ( 47.6) |